Dr. Sunil Wimalawansa is a university professor and a professor of medicine, and the former chief of the Division of Endocrinology, Metabolism and Nutrition at the Robert Wood Johnson Medical School & Robert Wood Johnson University Hospital; and professor of physiology and integrative biology at the University of Medicine and Dentistry of New Jersey, graduate school of biomedical sciences. In 2000, Dr. Wimalawansa completed a diploma in medical administration at the School of Business, Johns Hopkins University, and in 2006 earned an executive masters in business administration from Rutgers University.
Dr. Wimalawansa’s most recent scientific books are “Osteoporosis: Time to Act” and “Vitamin D. Everything you need to know.” He received young investigator awards from several professional societies, the Dr. Boy Frame Award for Clinical Excellence in Metabolic Bone Diseases (1993), multiple American Endocrine Society Glen Foundation Awards, and an innovation award from the Asian Chamber of Commerce.
He is the founding president of several non-profit organizations, including the International Foundation for Chronic Disabilities (ChronicDisabilities.org); the International Foundation for Revitalization, Empowerment, Education, and Development (I-FREED); the Hela empowerment foundation, international; the Wimalawansa Foundation; and the Wimalawansa Education Trust Fund for Needy Children. He sits on the board of directors of the American Association of Clinical Endocrinology (National AACE association and the AACE-state of New Jersey), Turners Foundation, and Samadhi Foundation. He is a member of the National Advisory Council on South Asian Affairs, and a retired Air Force squadron leader. In 2005, Dr. Wimalawansa received a coveted Lifetime Achievement Award from an international organization for his contributions to science, humanity, and society. The International Society for Clinical Densitometry recognized Dr. Wimalawansa’s humanitarian contributions by awarding him the 2007 Dr. Oscar S. Gluck Humanitarian award.
Dr. Wimalawansa’s research contributions were funded primarily by the NIH; in the fields of pharmaceuticals, peptides, peptide receptors, and metabolic bone diseases. He has developed once a week bisphosphonates therapy, combination therapies of estrogen and bisphosphonates, a technique to enhance the efficacy of bisphosphonates, and cost-effective therapies such as vitamin E and nitric oxide donor regimens for prevention and treatment of osteoporosis. In 1983/84, he was the first to developed and demonstrate the value of intraoperative hormone assays―calcitonin and parathyroid hormones markedly assisting surgical procedures. He served on several national and international scientific review committees, including NIH, DEA, and NASA. He is a board director, chair, or member of several national and international scientific committees, and has published over 130 peer-reviewed articles, 46 reviews and proceedings, 15 book chapters, and 4 books; has delivered 175 invited lectures and 280 scientific presentations, and holds 6 medical patents. He is a regular reviewer for more than 20 national and international scientific journals and served on several editorial boards. Recently, he developed a highly cost-effective water purification method to improve the quality of potable water, applicable worldwide and provide potable water for needy people.
Who’s Who: Professional of the Year link:
For publications, please visit the ResearchGate website: